close

Fundraisings and IPOs

1 2 3 4 72
Number of results: 1432
Date Company Amount Funding type Investors Therapeutic area Type of Information
2018-08-06 Pharmaxis (Australia) A$24 million (£13.4 million - €15.35 million) financing round Arix Bioscience (UK) BVF Partners (USA - CA) other existing shareholders Fibrotic diseases - Inflammatory diseases Financing round
2018-07-31 AC Immune (Switzerland) $117.5 million private placement Neurological diseases - CNS diseases Private placement
2018-07-28 Bluebird Bio (USA - MA) $550 million private placement Rare diseases - Genetic diseases Private placement
2018-07-23 Azafaros (The Netherlands) seed financing round BioGeneration Ventures (The Netherlands) Rare diseases - Genetic diseases - Metabolic diseases Financing round
2018-07-23 OliX Pharmaceuticals (South Korea) KRW43 billion ($38 million) IPO Fibrotic diseases - Ophtalmological diseases IPO
2018-07-06 Oncologie (USA - MA - China) $16.5 million seed financing round Nan Fung Life Sciences (China) Pivotal bioVenture Partners China Fund (China) China Merchant Bank Investments (China) Volcanics Ventures (China) Cancer - Oncology Financing round
2018-06-28 Innovation Pharmaceuticals (USA - MA) $7 million private placement Aspire Capital (USA - IL) Cancer - Oncology - Infectious diseases Private placement
2018-06-25 Avrobio (USA - MA) $114.7 million IPO Cancer - Oncology - Rare diseases - Genetic diseases - Lysosomal diseases IPO
2018-06-25 Akero Therapeutics (USA - MA) $65 Million series A financing round Apple Tree Partners (USA - NY) Atlas Venture (USA - MA) venBio Partners (USA - CA) Versant Ventures (USA - CA) Liver diseases - Hepatic diseases Series A financing round
2018-06-12 MeiraGTx (USA - NY) $75 million private placement Rare diseases - Genetic diseases Private placement
2018-05-30 Iontas (UK) £556 000 ($737 000) grant Innovate UK (UK) CNS diseases Grant
2018-05-29 Melinta Therapeutics (USA - CT) private placement Infectious diseases Private placement
2018-05-29 Mereo BioPharma (UK) private placement Rare diseases Private placement
2018-05-16 HiFiBiO Therapeutics (USA - MA) $37.5 million series B financing round Sequoia China (China) LYFE Capital (China) VI Ventures (China) Nest.Bio Ventures (USA - MA) Legend Star Capital (China) Proxima Ventures (Israel) Technology - Services Series B financing round
2018-05-09 IGEM Therapeutics (UK) £1.45 million grant Innovate UK (UK) Cancer - Oncology Grant
2018-05-08 InflaRX (Germany) $62.9 million private placement Inflammatory diseases Private placement
2018-05-07 Melinta Therapeutics (USA - CT) up to $6.2 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2018-05-03 Synpromics (UK) £1.9 million grant Scottish Enterprise (UK) Technology - Services Grant
2018-04-30 Sangamo Therapeutics (USA - CA) $230 million private placement Rare diseases - Genetic diseases Private placement
2018-04-27 Sangamo Therapeutics (USA - CA) $8 million grant California Institute for Regenerative Medicine (CIRM) (USA - CA) Rare diseases - Genetic diseases - Hematological diseases Grant